{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:17:37Z","timestamp":1787167057925,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Swedish Heart-Lung Foundation","doi-asserted-by":"crossref","award":["2014007"],"award-info":[{"award-number":["2014007"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALU"},{"name":"FOU-VGR"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijcard.2017.01.048","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T23:17:11Z","timestamp":1483658231000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study"],"prefix":"10.1016","volume":"232","author":[{"given":"Silvana","family":"Kontogeorgos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Thunstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus C.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcard.2017.01.048_bb0015","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9386","key":"10.1016\/j.ijcard.2017.01.048_bb0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijcard.2017.01.048_bb0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"2 Suppl","key":"10.1016\/j.ijcard.2017.01.048_bb0030","first-page":"III48","article-title":"Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group","volume":"81","author":"Cohn","year":"1990","journal-title":"Circulation"},{"issue":"4 Pt 1","key":"10.1016\/j.ijcard.2017.01.048_bb0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0002-8703(92)90709-5","article-title":"Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure","volume":"123","author":"Ghali","year":"1992","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2017.01.048_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population","volume":"168","author":"Cheng","year":"2014","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2017.01.048_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2014.02.018","article-title":"In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF outcome registry","volume":"173","author":"Senni","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.048_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2015-307782","article-title":"Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF","author":"Kang","year":"2015","journal-title":"Heart"},{"issue":"7\u20138","key":"10.1016\/j.ijcard.2017.01.048_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.repc.2015.02.002","article-title":"Clinical characteristics and prognosis of heart failure in elderly patients","volume":"34","author":"Martinez-Brana","year":"2015","journal-title":"Rev. Port. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2017.01.048_bb0060","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2017.01.048_bb0065","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2017.01.048_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ageing\/21.1.49","article-title":"Survival of elderly men with congestive heart failure","volume":"21","author":"Taffet","year":"1992","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.ijcard.2017.01.048_bb0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0002-8703(97)70057-7","article-title":"Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure","volume":"134","author":"McDermott","year":"1997","journal-title":"Am. Heart J."},{"issue":"1 Pt 1","key":"10.1016\/j.ijcard.2017.01.048_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0002-8703(99)70251-6","article-title":"Insights into the contemporary epidemiology and outpatient management of congestive heart failure","volume":"138","author":"McAlister","year":"1999","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2017.01.048_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9149(96)00719-9","article-title":"Course and prognosis in patients > or =70years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction","volume":"79","author":"Pernenkil","year":"1997","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2017.01.048_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.CIR.67.2.330","article-title":"Prognosis of patients with acute pulmonary edema and normal ejection fraction after acute myocardial infarction","volume":"67","author":"Warnowicz","year":"1983","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"van Riet","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2017.01.048_bb0100","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2017.01.048_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2017.01.048_bb0110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction","volume":"17","author":"Sanders-van Wijk","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2017.01.048_bb0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2017.01.048_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.442","article-title":"Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review","volume":"18","author":"Vaduganathan","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"14","key":"10.1016\/j.ijcard.2017.01.048_bb0125","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","volume":"33","year":"2012","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2017.01.048_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0195-668X(02)00845-X","article-title":"Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function","volume":"24","author":"Gustafsson","year":"2003","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2017.01.048_bb0140","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejhf.327","article-title":"Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response","volume":"17","author":"Kao","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.ijcard.2017.01.048_bb0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/ejhf.430","article-title":"Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use","volume":"17","author":"D'Elia","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"17","key":"10.1016\/j.ijcard.2017.01.048_bb0150","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0002-9149(90)91112-J","article-title":"Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease","volume":"66","author":"Aronow","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcard.2017.01.048_bb0160","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2012.14785","article-title":"Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction","volume":"308","author":"Lund","year":"2012","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.ijcard.2017.01.048_bb0165","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.104.519876","article-title":"Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report","volume":"112","author":"Fukuta","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2017.01.048_bb0175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1253\/circj.CJ-14-0865","article-title":"Prognostic impact of statin use in patients with heart failure and preserved ejection fraction","volume":"79","author":"Nochioka","year":"2015","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.ijcard.2017.01.048_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1124\/jpet.110.168724","article-title":"Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice","volume":"335","author":"Xia","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.ijcard.2017.01.048_bb0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317300803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317300803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T03:41:38Z","timestamp":1656214898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317300803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"alternative-id":["S0167527317300803"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.048","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}